Presenilin 2 influences miR146 level and activity in microglia

Journal of Neurochemistry

Volumn 127, Issue 5, 2013, Pages 592-599

  Jayadev, Suman ^a   Case, Amanda ^a   Alajajian, Betty ^a   Eastman, Alison J ^a   Möller, Thomas ^a   Garden, Gwenn A ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; microglia; miR146; neuroinflammation; presenilin

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MICRORNA 146A; PRESENILIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVITY; CELL ISOLATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; MICROGLIA; MOLECULAR DYNAMICS; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; WILD TYPE;

MURINAE;

ALZHEIMER DISEASE; MICROGLIA; MIR146; NEUROINFLAMMATION; PRESENILIN;

ANIMALS; ANIMALS, NEWBORN; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MICRORNAS; NF-KAPPA B; PRESENILIN-2; PRIMARY CELL CULTURE; TRANSCRIPTION, GENETIC;

EID: 84887613077     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12400     Document Type: Article

References (38)

1. Aguzzi A., Barres B. A., and, Bennett M. L., (2013) Microglia: scapegoat, saboteur, or something else? Science 339, 156-161.
2. Bartel D. P., (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
3. Beglopoulos V., Sun X., Saura C. A., Lemere C. A., Kim R. D., and, Shen J., (2004) Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J. Biol. Chem. 279, 46907-46914.
4. Boldin M. P., Taganov K. D., Rao D. S., et al,. (2011) miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208, 1189-1201.
5. Cao Z., Henzel W. J., and, Gao X., (1996) IRAK: a kinase associated with the interleukin-1 receptor. Science 271, 1128-1131.
6. Cruchaga C., Chakraverty S., Mayo K., et al,. (2012) Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS ONE 7, e31039.
7. De Strooper B., (2003) Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron 38, 9-12.
8. Flannery S., and, Bowie A. G., (2010) The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling. Biochem. Pharmacol. 80, 1981-1991.
9. Haapasalo A., and, Kovacs D. M., (2011) The many substrates of presenilin/gamma-secretase. J. Alzheimers Dis. 25, 3-28.
10. Hass M. R., Sato C., Kopan R., and, Zhao G., (2009) Presenilin: RIP and beyond. Semin. Cell Dev. Biol. 20, 201-210.
11. Hensley K., (2010) Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J. Alzheimers Dis. 21, 1-14.
12. Ho A., and, Shen J., (2011) Presenilins in synaptic function and disease. Trends Mol. Med. 17, 617-624.
13. Hou J., Wang P., Lin L., Liu X., Ma F., An H., Wang Z., and, Cao X., (2009) MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183, 2150-2158.
14. Jayadev S., Case A., Eastman A. J., Nguyen H., Pollak J., Wiley J. C., Moller T., Morrison R. S., and, Garden G. A., (2010a) Presenilin 2 is the predominant gamma-secretase in microglia and modulates cytokine release. PLoS ONE 5, e15743.
15. Jayadev S., Leverenz J. B., Steinbart E., Stahl J., Klunk W., Yu C. E., and, Bird T. D., (2010b) Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. Brain 133, 1143-1154.
16. Jiang M., Xiang Y., Wang D., Gao J., Liu D., Liu Y., Liu S., and, Zheng D., (2012) Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages. Aging Cell 11, 29-40.
17. Jorissen E., and, De Strooper B., (2010) Gamma-secretase and the intramembrane proteolysis of Notch. Curr. Top. Dev. Biol. 92, 201-230.
18. Kondo T., Kawai T., and, Akira S., (2012) Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol. 33, 449-458.
19. Kopan R., and, Ilagan M. X., (2004) Gamma-secretase: proteasome of the membrane? Nat. Rev. Mol. Cell Biol. 5, 499-504.
20. McGeer P. L., Schulzer M., and, McGeer E. G., (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47, 425-432.
21. Mei J., Bachoo R., and, Zhang C. L., (2011) MicroRNA-146a inhibits glioma development by targeting Notch1. Mol. Cell. Biol. 31, 3584-3592.
22. Motsch N., Pfuhl T., Mrazek J., Barth S., and, Grasser F. A., (2007) Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol. 4, 131-137.
23. Nahid M. A., Pauley K. M., Satoh M., and, Chan E. K., (2009) miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. J. Biol. Chem. 284, 34590-34599.
24. Newton K., and, Dixit V.M,. (2012). Signaling in innate immunity and inflammation. Cold Spring Harb. Perspect. Biol. 4, 5.
25. Nguyen H. N., Lee S. Y., Hwang D. Y., Kim Y. K., Yuk D. Y., Lee J. S., and, Hong J. T., (2005) Decrease in NF-kappaB, AP-1 and SP-1 activities in neuronal cells expressing presenilin 2. NeuroReport 16, 731-735.
26. O'Connell R. M., Rao D. S., and, Baltimore D., (2012) microRNA Regulation of Inflammatory Responses. Annu. Rev. Immunol. 30, 295-312.
27. O'Neill L. A., Sheedy F. J., and, McCoy C. E., (2011) MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat. Rev. Immunol. 11, 163-175.
28. Perry M. M., Moschos S. A., Williams A. E., Shepherd N. J., Larner-Svensson H. M., and, Lindsay M. A., (2008) Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J. Immunol. 180, 5689-5698.
29. Ponomarev E. D., Veremeyko T., and, Weiner H. L., (2013) MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 61, 91-103.
30. Ransohoff R. M., and, Cardona A. E., (2010) The myeloid cells of the central nervous system parenchyma. Nature 468, 253-262.
31. Saban M. R., Nguyen N. B., Hammond T. G., and, Saban R., (2002) Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation. Am. J. Pathol. 160, 2095-2110.
32. Shen J., and, Kelleher R. J., 3rd, (2007) The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc. Natl Acad. Sci. USA 104, 403-409.
33. Swantek J. L., Tsen M. F., Cobb M. H., and, Thomas J. A., (2000) IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J. Immunol. 164, 4301-4306.
34. Taganov K. D., Boldin M. P., Chang K. J., and, Baltimore D., (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. USA 103, 12481-12486.
35. Wolfe M. S., (2012) gamma-Secretase as a target for Alzheimer's disease. Adv. Pharmacol. 64, 127-153.
36. Yagi T., Giallourakis C., Mohanty S., Scheidig C., Shen J., Zheng H., Xavier R. J., and, Shaw A. C., (2008) Defective signal transduction in B lymphocytes lacking presenilin proteins. Proc. Natl Acad. Sci. USA 105, 979-984.
37. Zhao J. L., Rao D. S., Boldin M. P., Taganov K. D., O'Connell R. M., and, Baltimore D., (2011) NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc. Natl Acad. Sci. USA 108, 9184-9189.
38. Zheng J., Watanabe H., Wines-Samuelson M., Zhao H., Gridley T., Kopan R., and, Shen J., (2012) Conditional deletion of the Notch1 and Notch2 genes in excitatory neurons of the postnatal forebrain does not cause neurodegeneration or reduction of Notch mRNAs and proteins. J. Biol. Chem. 287, 20356-68.